Hematuria Evaluation and Management Following Resolved Sepsis and AKI

Initial Diagnostic Approach

The American Academy of Family Physicians recommends a comprehensive urologic evaluation including urinalysis with microscopy, urine culture, upper tract imaging, and cystoscopy to exclude malignancy and other urologic pathology in a patient with resolved sepsis and AKI who now presents with hematuria, while simultaneously assessing for residual renal parenchymal disease 1, 2
Examine the urine sediment carefully for dysmorphic red blood cells, red cell casts, and degree of proteinuria, as these findings suggest glomerular or renal parenchymal disease rather than urologic causes 1, 2
Quantify the number of RBCs per high-power field to confirm significant hematuria 2
Check for white blood cells and perform urine culture to exclude urinary tract infection as the cause 1, 2
If infection is present, treat appropriately and repeat urinalysis in 6 weeks; if hematuria resolves, no further evaluation is needed 2

Obtain imaging of the upper urinary tract using intravenous urography, ultrasonography, or computed tomography to detect renal cell carcinoma, transitional cell carcinoma, urolithiasis, or renal infection 1, 2
Perform cystoscopic examination of the urinary bladder to evaluate for bladder pathology, particularly urothelial malignancies which are the most commonly detected cancers in patients with microscopic hematuria 1, 2
Consider voided urinary cytology, especially if risk factors for transitional cell carcinoma are present (age >40, smoking history, occupational exposures, prior pelvic radiation, chronic cyclophosphamide use) 2
If cytology shows malignant or atypical cells, cystoscopy is mandatory 2

Do not use NSAIDs for any concurrent symptoms, as these are nephrotoxic and contraindicated in patients with recent AKI 3, 4
Minimize exposure to additional nephrotoxins, as each additional nephrotoxin increases AKI odds by 53% 5
Patients with prior AKI require ongoing surveillance for hypertension, progressive renal disease, proteinuria, and cardiovascular complications 1, 2
If isolated hematuria persists after negative urologic evaluation and no glomerular disease is identified, follow for development of hypertension, renal insufficiency, or proteinuria 1, 2

Do not assume hematuria is simply residual from the AKI without proper evaluation, as this could miss treatable malignancies or other serious pathology 1, 2
Do not delay evaluation if hematuria persists, as urothelial cancers require early detection 1, 2
Do not perform renal biopsy in isolated hematuria without risk factors for primary renal disease, as the role of biopsy in this setting is not well-defined 1, 2
In women, ensure proper specimen collection to avoid vaginal contamination; consider catheterized specimen if clean-catch is unreliable 2